Antibodies were detected against GAD in 1 (3%), APL in 1 (3%), NMDA-R in 2 (6.1%), CV2 in 1 (3.0%), Tr in 1 (3.0%), GABA in 11 (33.3%), recoverin in 1 (3.0%), dsDNA in 1 (3.0%) of our patients with focal epilepsy (Table 2). This evidence concerns the gene FASLG and focal epilepsy.